<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Metagenomics which combines the power of genomics, bioinformatics, and systems biology, provide new access to the microbial world </plain></SENT>
<SENT sid="1" pm="."><plain>Metagenomics permit the genetic analysis of complex microbial populations without requiring prior cultivation </plain></SENT>
<SENT sid="2" pm="."><plain>Through the conceptual innovations in metagenomics and the improvements in DNA high-throughput sequencing and bioinformatics analysis technology, gastrointestinal microbiology has entered the metagenomics era and become a hot topic worldwide </plain></SENT>
<SENT sid="3" pm="."><plain>Human microbiome research is underway, however, most studies in this area have focused on the composition and function of the intestinal microbiota and the relationship between intestinal microbiota and <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e> (<z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, etc.) and <z:e sem="disease" ids="C0021831" disease_type="Disease or Syndrome" abbrv="">intestinal disorders</z:e> [<z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:e sem="disease" ids="C0022104" disease_type="Disease or Syndrome" abbrv="IBS">irritable bowel syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>), etc.] </plain></SENT>
<SENT sid="4" pm="."><plain>Few investigations on microbiota have been conducted within the upper gastrointestinal tract (esophagus, stomach and duodenum) </plain></SENT>
<SENT sid="5" pm="."><plain>The upper gastrointestinal microbiota is essential for several gastrointestinal illnesses, including <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and <z:hpo ids='HP_0011459'>esophageal carcinoma</z:hpo>, <z:hpo ids='HP_0005263'>gastritis</z:hpo> and <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, small intestinal <z:mp ids='MP_0001794'>bacterial</z:mp> <z:hpo ids='HP_0001548'>overgrowth</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> and <z:hpo ids='HP_0002608'>celiac disease</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>However, the constitution and diversity of the microbiota in different sections of the upper gastrointestinal tract under health and various <z:mp ids='MP_0002054'>disease states</z:mp>, as well as the function of microbiota in the pathogenesis of various <z:e sem="disease" ids="C0012242" disease_type="Disease or Syndrome" abbrv="">digestive diseases</z:e> are still undefined </plain></SENT>
<SENT sid="7" pm="."><plain>The current article provides an overview of the recent findings regarding the relationship between upper gastrointestinal microbiota and <z:e sem="disease" ids="C0017178" disease_type="Disease or Syndrome" abbrv="">gastrointestinal diseases</z:e>; and discusses the study limitations and future directions of upper gastrointestinal microbiota research </plain></SENT>
</text></document>